Billing Manual

Total Page:16

File Type:pdf, Size:1020Kb

Billing Manual BILLING GUIDE for Laboratory Test Requisitions Provided for the clients of P ATHOLOGY ASSOCIATES MEDICAL LABORATORIES P ACL AB NETWORK LABORATORIES T RI-CITIES LABORATORY T REASURE VALLEY LABORATORY A LPHA MEDICAL LABORATORY For more information, please contact your local representative. © 2000 by Pathology Associates Medical Laboratories. (509) 927-6250 • 1-800-433-1583 2 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 Contents SECTION 1 29 Outpatient Diagnostic Coding & Reporting Guidelines 5 Introduction 29 Outpatient Coding Guidelines 5 How Our Billing Expertise Can Help You 32 Customized ICD·9 Requisition Policy 5 The Importance of Diagnosis Codes 33 Customized ICD·9 Requisition Request Form 34 Customized ICD·9 Requisition Sample SECTION 2 7 Client Billing SECTION 7 9 Successful Laboratory Requisitions, Client Billing 43 Medicare Billing 45 Successful Laboratory Requisitions, Medicare Billing SECTION 3 46 Medicare Waivers 11 Insurance Billing 47 Advance Beneficiary Notice 13 Successful Laboratory Requisitions, Insurance Billing 48 Advance Beneficiary Notice Sample 14 Unusual & Important Information on Specific Insurance Carriers 49 Medicare Secondary Payer 16 Requirements of Specific Insurance Companies 50 Medicare Secondary Payer Questions 51 Tests Requiring Proof of Medical Necessity ID Medicare B SECTION 4 52 Tests Requiring Proof of Medical Necessity WA Medicare A1 21 Washington Public Assistance 53 Tests Requiring Proof of Medical Necessity WA Medicare A2 23 Successful Laboratory Requisitions, WA Public Assistance Billing 54 Tests Requiring Proof of Medical Necessity WA Medicare B SECTION 5 SECTION 8 25 Washington Healthy Options 55 LMRPs – Idaho Medicare 27 Successful Laboratory Requisitions, Healthy Option Billing 56 Warranty and Liability Disclaimer 28 Sample Medical Assistance ID (MAID) Card With HIC Number 28 Sample Medical Assistance ID (MAID) Healthy Options Card SECTION 9 29 Healthy Options and Managed Care 71 LMRPs – Washington Medicare A 72 Warranty and Liability Disclaimer SECTION 6 31 Correct Coding SECTION 10 32 Top Ten Most Common Invalid ICD·9 Codes 79 LMRPs – Washington Medicare B 34 ICD·9 Coding Diagnostic Requirements 80 Warranty and Liability Disclaimer 35 ESRD Claims and Diagnoses SEPTEMBER 2000 3 (509) 927-6250 • 1-800-433-1583 4 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 INTRODUCTION Introduction How Our Billing Expertise Can Help You ■ Extensive relationships with payers throughout the region; including most electronic billing systems. ■ ICD·9 coding education available. ■ Periodic test mix summaries illustrating utilization of lab procedures by physicians. ■ Convenient, professional direct billing available for your patients. ■ Reports detailing patient charges including procedure, bill type, and cost. ■ Local, in-state billing staff with convenient toll-free service. The Importance of Diagnosis Codes In today’s regulated health care climate, ICD·9 diagnosis codes are becoming mandatory. When requisitions arrive without an accept- able code or a signed waiver, we might not be reimbursed for our services. Please assist us by providing this required information at the time you order a test, and we’ll all save time and frustration. If you have any questions regarding this issue, please contact your service representative or the laboratory billing department. We are pleased to provide various tools designed to help you. These include staff training, laminated diagnosis code quick-reference cards, waiver forms, waiting room signs, etc. SEPTEMBER 2000 5 INTRODUCTION (509) 927-6250 • 1-800-433-1583 ICD-9 Coding Support. We can provide support for your ICD·9 coding efforts. Assistance in this increasingly vital area includes staff training, laminated diagnosis code quick- reference cards, waiver forms, waiting room signs, and more. We have the Dedicated Billing Professionals. Knowledgeable billing pro- fessionals are always accessible. Beyond the convenience of experience, resources, ready access to assistance, clients have the assurance that comes from decades of experience with payers operating in and technology to help Washington and throughout the Pacific Northwest. Experience Where It Counts. Our billing professionals have both you and your the depth and breadth of experience that makes a difference. In fact, our billing employees average eight years with the de- patients navigate partment. the increasingly Extensive Payer Relationships. We provide support to your patients by billing a wide variety of insurance companies complex billing directly. In an effort to serve our clients even better, we con- tinually monitor patient usage patterns of various carriers and environment. their associated programs, adding to the list of insurers billed on an ongoing basis. Toll-Free Phone Support. Providing service throughout Washington and the Pacific Northwest, members of the labo- ratory billing team are available to you and your patients via our toll-free number. Ethical Billing Standards. As a member of the Sisters of Providence family, PAML is pledged to adhere to the strictest code of billing ethics. 6 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 CLIENT BILLING Client Billing SEPTEMBER 2000 7 CLIENT BILLING (509) 927-6250 • 1-800-433-1583 1 8 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 CLIENT BILLING Client Billing When you would like us to bill directly to your office Successful Laboratory Requisitions, Client Billing Would you like us to bill you (clinician) directly for these services, and not your patients or their insurance? 1. Circle DR/HOSP/CLINIC in the Bill To: section of the requisition. Do not provide patient billing demographics, such as address and billing information. SEPTEMBER 2000 9 CLIENT BILLING (509) 927-6250 • 1-800-433-1583 10 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 INSURANCE BILLING Insurance Billing SEPTEMBER 2000 11 INSURANCE BILLING (509) 927-6250 • 1-800-433-1583 1 7 7 7 2 3 4 8 9 5 10 6 11 12 13 12 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 INSURANCE BILLING Insurance Billing When you would like us to bill the patient or insurance company directly. Successful Laboratory Requisitions, Insurance Billing The following insurance company billing requirements will assist you to accurately complete laboratory requisitions. The objective is to minimize recurring phone calls to our valued clients and ser- vice center employees. Thank you for your attention to detail. When billing insurance companies, the following information is Please provide an ICD-9 Code always required on the laboratory requisition: for every patient encounter. 1. Patient’s full name 2. Patient’s sex 3. Patient’s date of birth 4. Patient phone number 5. Responsible party’s name (if not patient) 6. Responsible party’s full address 7. Date and time of collection and fasting status 8. Whom is to be billed (Circle patient, doctor, Medicare, PA, or other) Additional information may be 9. Patient’s Social Security Number unique to specific insurances. Please review the requirements of 10. Insurance company name the enclosed primary insurance 11. Insurance ID number companies that we bill. 12. Insurance group number 13. Test ordered checked with proper and valid ICD·9 noted beside 14. Attached copy of insurance card, front and back SEPTEMBER 2000 13 INSURANCE BILLING (509) 927-6250 • 1-800-433-1583 Unusual and Important Information on Specific Insurance Carriers Reminder: Patient’s Full Demographics – including SSN, address, date of birth, phone number, guarantor, and complete insurance information and numbers are required for all requests to bill insurance. Please provide an ICD·9 code for each laboratory procedure requested. Washington Public Assistance ■ Provide Healthy Options or private health-care information when HMO column is marked on coupon. ■ Provide Medicare information when HIC is marked on coupon. ■ Always provide copy of patient insurance cards and DSHS coupon. Regence and other Blue Shields ■ Diagnosis code(s) are required. ■ Claims cannot be submitted to the insurer without a code. ■ Include 3-letter alpha prefix on insurance numbers. ■ Provide group number and county name (e.g., Whatcom). First Choice Network and N.E.I.C. Clearinghouse ■ Provide insurance number, group number and insurance company name. ■ Provide front and back copies of insurance card. Medicare ■ Diagnosis code(s) are critical. ■ Provide patient’s complete Medicare number. ■ Obtain a waiver if the test may be denied as medically unnecessary. 14 SEPTEMBER 2000 (509) 927-6250 • 1-800-433-1583 INSURANCE BILLING Labor & Industries ■ We bill state and self-funded plans. ■ Provide SSN, claim number, date of injury, nature of injury, and employer at time of injury. Group Health Cooperative ■ Diagnosis code(s) are required. ■ Provide patient’s Medical Record Number. ■ Provide patient’s Social Security Number. Premera (Blue Cross and MSC) Physicians Health Network (PHN) NW Physicians Network (NPN) Pro Health Alliance (PHA) Prime Net Pierce Unicare Lewis County MSO Managed Care Specialist Referrals Private Health Care Systems (PHCS) ■ Please ALWAYS indicate when a patient is covered under one of the above provider networks. Provide the name of the network as indi- cated above, patient insurance number and group number, and the name of the insurance company or administrator (e.g., Blue Cross). ■ Provide copy of insurance card, front and back. SEPTEMBER 2000 15 INSURANCE BILLING (509) 927-6250 • 1-800-433-1583 Requirements of Specific Insurance Companies ✔ A Third Party Administrator ✔ Blue Cross Basic Health ✔ Acordia
Recommended publications
  • Absolute Risk, 252 Acetabular Dysplasia, 38, 211, 213 Acetabular Protrusion, 38 Achondroplasia, 195, 197, 199–200, 205 Genetic
    Cambridge University Press 978-0-521-86137-3 - Palaeopathology Tony Waldron Index More information Index absolute risk, 252 angular kyphosis acetabular dysplasia, 38, 211, 213 in Scheuermann’s disease, 45 acetabular protrusion, 38 in tuberculosis, 93–4 achondroplasia, 195, 197, 199–200, 205 ankylosing spondylitis, 57–60, 65 genetic defect in, 199 ankylosis in, 58 skeletal changes in, 200 bamboo spine in, 59 acoustic neuroma, 229–31 erosions in, 59 acromegaly, 78, 207–8 first description, 57 and DISH, 208 HLA B27 58 and, skeletal changes in, 208 operational definition of, 59 acromelia, 198 prevalence of, 58 aDNA sacroiliitis and, 59 in leprosy, 101 skip lesions in, 59 in syphilis, 108 ankylosis, 51 in tuberculosis, 92, 95–6 following fracture, 146 Albers-Schonberg˝ disease, see in ankylosing spondylitis, 58 osteopetrosis in brucellosis, 96 Alstrom syndrome, 78 in DISH, 73 alveolar margin, see periodontal disease in erosive osteoarthritis, 55 amputation, 158–61 in rheumatoid arthritis, 51 indications for, 160–1 in septic arthritis, 89 ancient DNA, see aDNA in tuberculosis, 93–4 anaemia, 136–7 annulus fibrosus, 42–3, 45 cribra obitalia and, 136–7 ante-mortem tooth loss, 238–9 aneurysms, 224–7 and periodontal disease, 238–9 aortic, 224–5 and scurvy, 132 and syphilis, 224 causes of, 238 of vertebral artery, 225–6 anterior longitudinal ligament popliteal, 226 in ankylosing spondylitis, 59 aneurysmal bone cyst, 177 in DISH, 73 angiosarcoma, 182 anti-CCP antibodies, 49, 53 © Cambridge University Press www.cambridge.org Cambridge University Press
    [Show full text]
  • Imaging in Gout and Other Crystal-Related Arthropathies 625
    ImaginginGoutand Other Crystal-Related Arthropathies a, b Patrick Omoumi, MD, MSc, PhD *, Pascal Zufferey, MD , c b Jacques Malghem, MD , Alexander So, FRCP, PhD KEYWORDS Gout Crystal arthropathy Calcification Imaging Radiography Ultrasound Dual-energy CT MRI KEY POINTS Crystal deposits in and around the joints are common and most often encountered as inci- dental imaging findings in asymptomatic patients. In the chronic setting, imaging features of crystal arthropathies are usually characteristic and allow the differentiation of the type of crystal arthropathy, whereas in the acute phase and in early stages, imaging signs are often nonspecific, and the final diagnosis still relies on the analysis of synovial fluid. Radiography remains the primary imaging tool in the workup of these conditions; ultra- sound has been playing an increasing role for superficially located crystal-induced ar- thropathies, and computerized tomography (CT) is a nice complement to radiography for deeper sites. When performed in the acute stage, MRI may show severe inflammatory changes that could be misleading; correlation to radiographs or CT should help to distinguish crystal arthropathies from infectious or tumoral conditions. Dual-energy CT is a promising tool for the characterization of crystal arthropathies, partic- ularly gout as it permits a quantitative assessment of deposits, and may help in the follow-up of patients. INTRODUCTION The deposition of microcrystals within and around the joint is a common phenomenon. Intra-articular microcrystals
    [Show full text]
  • Geriatric Rheumatology: a Comprehensive Approach Encourages You to Think from the Older Patient’S Perspective
    Geriatric Rheumatology wwwwwwwwwwwwwwwwwwwwww Yuri Nakasato • Raymond L. Yung Editors Geriatric Rheumatology A Comprehensive Approach Editors Yuri Nakasato Raymond L. Yung Sanford Health Systems Department of Internal Medicine Fargo, ND, USA University of Michigan [email protected] Ann Arbor, Michigan, USA [email protected] ISBN 978-1-4419-5791-7 e-ISBN 978-1-4419-5792-4 DOI 10.1007/978-1-4419-5792-4 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2011928680 © Springer Science+Business Media, LLC 2011 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
    [Show full text]
  • Psoriasis, Psoriatic Arthritis and Secondary Gout – 3 Case Reports
    https://doi.org/10.5272/jimab.2018242.1972 Journal of IMAB Journal of IMAB - Annual Proceeding (Scientific Papers). 2018 Apr-Jun;24(2) ISSN: 1312-773X https://www.journal-imab-bg.org Case report PSORIASIS, PSORIATIC ARTHRITIS AND SECONDARY GOUT – 3 CASE REPORTS Mina I. Ivanova, Rositsa Karalilova, Zguro Batalov. Departement of Rheumatology, Faculty of Medicine, UMHAT Kaspela, Medical University - Plovdiv, Bulgaria. ABSTRACT: cells in the skin (Langerhans cells) migrate to the regional Background: One of the most common complica- lymph nodes, where interacts with T-lymphocytes. This tions in psoriasis is the development of secondary gout that provokes the immune response leading to the activation often remains undiagnosed for many years. In some cases, of T cells and release of cytokines. The local effects of the clinical symptoms of gout precede the manifestation cytokines lead to a cell-mediated immune response. In pso- of cutaneous psoriasis, leading to progression of the dis- riasis skin lesions are results of hyperplasia of the epider- ease and early onset of complications. According to the mis, which leads to enhanced cell reproduction, world data, there is a strong correlation between psoriasis hyperproliferation and at the same time shortening vulgaris and psoriatic arthritis on the one hand and gout keratinocytes’ life. This leads to increased production of on the other ranging from 3 to 40%. In Bulgaria, there are uric acid, as it enhances the exchange of nucleic acids. no studies observing the frequency of secondary gout in Psoriatic arthritis (PsA) occurs in 0.05 to 0.25% from psoriatic patients. the general population.
    [Show full text]
  • Crystal Deposition in Joints: Prevalence and Relevance for Arthritis
    Editorial Crystal Deposition in Joints: Prevalence and Relevance for Arthritis Within the present world of arthritis research and practice, surfaces as one manifestation of systemic urate metabolism investigators of crystal-associated arthritis appear to be a disorders13. While MSU crystals deposit on cartilage sur- small, aging, and dwindling endangered species whose faces, these crystals can accumulate and erode into carti- interests are seen to be peripheral to those of most rheuma- lage. In contrast, CPPD crystal deposition is restricted to tologists. This contrasts dramatically with the high preva- hyaline and fibrocartilages and reflects a metabolic disorder lence of these diseases1,2. Both gout [urate crystal within cartilage itself14. While CPPD crystals have been (monosodium urate, MSU) arthropathy] and pseudogout said to form principally in cartilage mid-zone, this study [calcium pyrophosphate dihydrate (CPPD) crystal arthropa- and our own unpublished observations show that CPPD thy] are common and distinct forms of arthritis that were crystals can form in hyaline cartilage superficial zones, distinguished and characterized clinically decades ago3-7. It within the cartilage surface and sometimes without deeper is easy to speculate on the reasons for the current clinical underlying deposits. MSU and CPPD crystal deposits on lack of interest. These include: specific therapy for gout, cartilage surfaces cannot be distinguished from each other absence of specific therapy for pseudogout, and blurring of by the naked eye. However, these crystals can be identified the clinical distinction between these diseases and by experienced observers using compensated polarized osteoarthritis (OA). It is an important but separate issue that light microscopy or by more elaborate methods such as OA itself, as a clinical disease descriptor, encompasses a Fourier transform infra-red spectroscopy or powder x-ray or wide range of diseases, distinguished only sometimes as pri- electron diffraction.
    [Show full text]
  • Arthritis and Other Rheumatic Disorders ICD-9-CM to ICD-10-CM Estimated Crosswalk
    AORC ICD-9-CM to ICD-10-CM Conversion Codes Arthritis and Other Rheumatic Disorders ICD-9-CM to ICD-10-CM Estimated Crosswalk ICD-9-CM ICD-10-CM Osteoarthritis and allied disorders 715 Osteoarthrosis generalized, site unspecified M15.0 Primary generalized (osteo)arthritis M15.9 Polyosteoarthritis, unspecified 715.04 Osteoarthrosis, generalized, hand M15.1 Heberden's nodes (with arthropathy) M15.2 Bouchard's nodes (with arthropathy) 715.09 Osteoarthrosis, generalized, multiple sites M15.0 Primary generalized (osteo)arthritis 715.1 Osteoarthrosis, localized, primary, site unspecified M19.91 Primary osteoarthritis, unspecified site 715.11 Osteoarthrosis, localized, primary, shoulder region M19.019 Primary osteoarthritis, unspecified shoulder 715.12 Osteoarthrosis, localized, primary, upper arm M19.029 Primary osteoarthritis, unspecified elbow 715.13 Osteoarthrosis, localized, primary, forearm M19.039 Primary osteoarthritis, unspecified wrist 715.14 Osteoarthrosis, localized, primary, hand M19.049 Primary osteoarthritis, unspecified hand 715.15 Osteoarthrosis, localized, primary, pelvic region and thigh M16.10 Unilateral primary osteoarthritis, unspecified hip 715.16 Osteoarthrosis, localized, primary, lower leg M17.10 Unilateral primary osteoarthritis, unspecified knee 715.17 Osteoarthrosis, localized, primary, ankle and foot M19.079 Primary osteoarthritis, unspecified ankle and foot 715.18 Osteoarthrosis, localized, primary, other specified sites M19.91 Primary osteoarthritis, unspecified site 715.2 Osteoarthrosis, localized, secondary,
    [Show full text]
  • Arthritis Due to Deposition Diseases: Differential Diagnosis in Conventional Radiology
    Arthritis due to deposition diseases: differential diagnosis in conventional radiology Poster No.: C-1599 Congress: ECR 2016 Type: Educational Exhibit Authors: A. P. Pissarra, R. R. Domingues Madaleno, I. Abreu, B. Graça, F. Caseiro Alves; Coimbra/PT Keywords: Education and training, Arthritides, Education, Diagnostic procedure, Conventional radiography, Musculoskeletal joint, Bones, Extremities DOI: 10.1594/ecr2016/C-1599 Any information contained in this pdf file is automatically generated from digital material submitted to EPOS by third parties in the form of scientific presentations. References to any names, marks, products, or services of third parties or hypertext links to third- party sites or information are provided solely as a convenience to you and do not in any way constitute or imply ECR's endorsement, sponsorship or recommendation of the third party, information, product or service. ECR is not responsible for the content of these pages and does not make any representations regarding the content or accuracy of material in this file. As per copyright regulations, any unauthorised use of the material or parts thereof as well as commercial reproduction or multiple distribution by any traditional or electronically based reproduction/publication method ist strictly prohibited. You agree to defend, indemnify, and hold ECR harmless from and against any and all claims, damages, costs, and expenses, including attorneys' fees, arising from or related to your use of these pages. Please note: Links to movies, ppt slideshows and any other multimedia files are not available in the pdf version of presentations. www.myESR.org Page 1 of 30 Learning objectives The purpose of this article is to describe the typical imaging findings on plain film of deposition diseases arthropathies, differentiating them according to their radiographic appearance and body segments most commonly affected by the substance deposition.
    [Show full text]
  • Crystal Arthropathy
    UPDATED MANAGEMENT OF CRYSTAL ARTHROPATHY Professor Md. Mahabubul Islam Majumder Head, Department of medicine. Cumilla medical college Crystal arthropathies are a diverse group of disorders characterized by the deposition of various minerals in joints and soft tissues, leading to inflammation. 5 times common in men and seldom in premenopausal women. Incidence is increasing due to in ageing population, hypertension, diabetes mellitus and hyperlipidaemia. Stan way J et al. Medicine. March 2018Volume 46, Issue 3, Pages 181–186, DOI: BChttps://doi.org/10.1016/j.mpmed.2017.12.003 Gout - the most common crystal arthropathy, by monosodium urate crystal- also called “threshold" disease. 2 other commons are -calcium pyrophosphate dihydrate, causing Pseudogout, and Basic calcium phosphate (hydroxyapatite) arthropathy. Minors are - Oxalate and Depot corticosteroid Crystal, liquid lipid crystal, hematoidin, immunoglobulin, Charcot-Leyden Crystal, foreign bodies. GOUT CPPD HADD Stan way J et al. Medicine. March 2018Volume 46, Issue 3, Pages 181–186, DOI: BChttps://doi.org/10.1016/j.mpmed.2017.12.003. Dhanda and Quek, J Arthritis 2016, 5:6. DOI: 10.4172/2167-7921.1000i102 Differential diagnosis of crystal arthritis- - Septic arthritis - Cellulitis - Trauma/haemarthrosis - Palindromic rheumatism C Reactive arthritis - Psoriatic/rheumatoid arthritis C UpToDate 2018 Gout has transformed ‘Disease of kings’ to ‘Disease of commoners’ Prevalence of gout increased in past few decades. Higher in men than women- onset 4-6 decades. 5% female suffers gout. Adiposity is strongest risk of gout. Tophi are a cardinal feature of gout. Red meat and seafood increase risk of gout. Purine rich plant food not associated with gout. Among alcoholic beverages- Beer has high risk.
    [Show full text]
  • (Crystal Arthropathies) Gout and Pseudogout Pathophysiology
    Gout and pseudogout (crystal arthropathies) Gout and pseudogout pathophysiology Gout and pseudogout are crystal arthropathies Crystals of urate (in gout) and calcium pyrophosphate (in pseudogout) are precipitated in joints Neutrophils phagocytose the crystals whilst releasing pro-inflammatory cytokines which trigger attacks Asymptomatic deposition of crystals between attacks is normal; what triggers an attack is unknown Risk factors for gout (causes of hyperuricaemia) Alcohol Chronic renal disease Hypertension, hyperlipidaemia, diabetes i.e. cardiovascular risk factors (majority of cases) Medications o Diuretics, aspirin Malignancy (high cell turnover) o Lymphoproliferative and myeloproliferative disorders Certain genetic disorders e.g. G6PD Risk factors for pseudogout Association with trauma and osteoarthritis Hyperparathyroidism Wilson’s disease Haemochromatosis Loop diuretics causing hypomagnasaemia Presentation of gout (presents in four ways): 1. Acute urate synovitis (acute attack of gout – what is mainly covered here). o Classically, acute gout affects the first MTP (podagra): initial presentation in 50%. o Other joints include ankles, wrists, fingers & knees. o Clinical features are sudden onset exquisite tenderness, swelling, redness. 2. Polyarticular gout o Initial presentation in 10%, particularly elderly women 3. May become chronic where it can resemble rheumatoid o May have gouty tophi: smooth, white deposits of uric acid in the skin and around joints 4. Urate renal stone formation o Can precede gout in 15%
    [Show full text]
  • Arthropathies Associated with Basic Calcium Phosphate Crystals
    Scanning Microscopy Volume 6 Number 3 Article 14 9-8-1992 Arthropathies Associated with Basic Calcium Phosphate Crystals Paul B. Halverson Medical College of Wisconsin Follow this and additional works at: https://digitalcommons.usu.edu/microscopy Part of the Biology Commons Recommended Citation Halverson, Paul B. (1992) "Arthropathies Associated with Basic Calcium Phosphate Crystals," Scanning Microscopy: Vol. 6 : No. 3 , Article 14. Available at: https://digitalcommons.usu.edu/microscopy/vol6/iss3/14 This Article is brought to you for free and open access by the Western Dairy Center at DigitalCommons@USU. It has been accepted for inclusion in Scanning Microscopy by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. Scanning Microscopy, Vol. 6, No. 3, 1992 (Pages 791-797) 0891-7035/92$5.00+ .00 Scanning Microscopy International, Chicago (AMF O'Hare), IL 60666 USA ARTHROPATHIES ASSOCIATED WITH BASIC CALCIUM PHOSPHATE CRYSTALS Paul B. Halverson Division of Rheumatology, Medical College of Wisconsin, 8700 W. Wisconsin Avenue, Milwaukee, WI 53226 Phone: 414-447-2597 (Received for publication July 23, 1992, and in revised form September 8, 1992) Abstract Introduction Basic calcium phosphate (BCP) crystals refer to a Basic calcium phosphate (BCP) crystals, usually re­ family of crystals including partially carbonate substi­ ferred to as "apatite" or hydroxyapatite, actually consist tuted hydroxyapatite, octacalcium phosphate, and trical­ of mixtures of partially carbonate-substituted hydroxy­ cium phosphate. These crystals have been found in and apatite, octacalcium phosphate, and tricalcium phosphate around joints and have been associated with several [39]. The latter two species may represent transition forms of arthritis and periarthritis .
    [Show full text]
  • Polyarthritis and Its Differential Diagnosis Nilüfer Alpay-Kanıtez1 , Selda Çelik2 , Cemal Bes2 Abstract
    DOI: 10.5152/eurjrheum.2019.19145 Invited Review Polyarthritis and its differential diagnosis Nilüfer Alpay-Kanıtez1 , Selda Çelik2 , Cemal Bes2 Abstract Polyarthritis is a term used when at least five joints are affected with arthritis. Several different dis- eases ranging from rheumatoid arthritis to infection diseases can lead to polyarthritis. Anamnesis, physical examination, laboratory findings and imaging methods are important tools to differential diagnosis. Keywords: Polyarthritis, differential diagnosis, laboratory investigations Introduction Polyarthritis refers to a joint disease that involves at least five joints. One or more signs of inflammation, including pain, movement restriction, swelling, warmth, and redness, are seen in the joints involved. In the event that pain is the only symptom, it is difficult to differentiate polyarthritis from the causes of polyarticular joint pain (PJP), such as fibromyalgia or osteoarthritis. Imaging methods such as ultra- sonography and magnetic resonance may be helpful in differentiating arthralgia from arthritis. Table 1 illustrates the diseases and their clinical characteristics that are frequently seen in clinical practice and cause non-inflammatory PJP. In some cases, polyarthritis can be severe enough to necessitate the admission of patients to emergency services, or it can be asymptomatic and may remain undiagnosed for months. Several diseases ranging from rheumatic arthritis (RA) to infectious diseases can lead to polyarthritis. Anamnesis, physical exam- ination, laboratory findings, and imaging methods are the tools that support an accurate diagnosis. Herein, we aimed to underline the differential diagnosis of a patient with polyarthritis and in doing so, contribute to clinical practice. Clues for differential diagnosis ORCID IDs of the authors: N.A.K.
    [Show full text]
  • OSTEOARTHROSIS in the GENERAL POPULATION a Follow-Up Study of Osteoarthrosis of The
    OSTEOARTHROSIS IN THE GENERAL POPULATION A follow-up study of osteoarthrosis of the hip OSTEOARTHROSIS IN THE GENERAL POPULATION A follow-up study of osteoarthrosis of the hip ARTROSE IN DE BEVOLKING Een vervolgonderzoek naar artrose van de heup PROEFSCHRIFT TER VERKRIJGING VAN DE GRAAD VAN DOCTOR AAN DE ERASMUS UNIVERSITEIT ROTTERDAM OP GEZAG VAN DE RECTOR MAGNIFICUS PROF. DR. A.H.G. RINNOOY KAN EN VOLGENS BESLUIT VAN HET COLLEGE VAN DEKANEN. DE OPENBARE VERDEDIGING ZAL PLAATSVINDEN OP WOENSDAG 17 MEl 1989 DES NAMIDDAGS TE 13.45 UUR door JOHANNES LEONARDUS CORNELIS MARIA VAN SAASE geboren te Hazerswoude PROMOTOR : Prof. Dr. H.A. Valkenburg OVERIGE LEDEN : Prof. Dr. A. Cats Prof. Dr. B. van Linge Prof. Dr. E van der Does CO-PROMOTOR : Dr. L.K.J. van Romunde Our knowledge of osteoarthrosis is incomplete, perhaps beause it is one of those dull commonplace disorders that are hard to study with enthusiasm, but new knowledge of osteoarthrosis must be gained if the later years of our lengthening lives are not to be plagued by increasing pain and disability. J.H. Kellgren Osteoarthrosis in Patients and Populations British Medical· Journal 1961 ;2: 1-3 Voor mijn ouders, Marisol, Claudia and Viviana Cover: The Beggars. Hieronymus Bosch (1450-1516) Copyright by Albertina Museum, Vienna Acknowledgement A generous grant from the Netherlands Society of Rheumatology permitted time for the completion of this investigation. The EPOZ study, the framework in which the investigation was conducted, was supported by grants from the Netherlands Prevention Fund. Additional funding was provided by 3M Nederland B.V.
    [Show full text]